Sökning: L773:1897 5593 OR L773:1898 018X >
The subcutaneous im...
The subcutaneous implantable cardioverter-defibrillator : A tertiary center experience
-
- Khazen, Cesar (författare)
- Med Univ Vienna, Dept Surg, Div Cardiac Surg, Vienna, Austria
-
- Magnusson, Peter (författare)
- Karolinska Institutet,Uppsala universitet,Centrum för klinisk forskning, Gävleborg
-
- Flandorfer, Johannes (författare)
- Univ Appl Sci, Krems, Austria
-
visa fler...
-
- Schukro, Christoph (författare)
- Med Univ Vienna, Div Cardiol, Dept Internal Med 2, Vienna, Austria
-
visa färre...
-
(creator_code:org_t)
- 2019
- 2019
- Engelska.
-
Ingår i: CARDIOLOGY JOURNAL. - 1897-5593 .- 1898-018X. ; 26:5, s. 543-549
- Relaterad länk:
-
https://doi.org/10.5...
-
visa fler...
-
https://uu.diva-port... (primary) (Raw object)
-
https://urn.kb.se/re...
-
https://doi.org/10.5...
-
http://kipublication...
-
visa färre...
Abstract
Ämnesord
Stäng
- Background:The aim of the study was to evaluate subcutaneous implantable cardioverter-defibrillator (S-ICD) patients with regard to underlying etiology, peri-procedural outcome, appropriate/inappropriate shocks, and complications during follow-up.Methods: All patients who underwent S-ICD implantation from February 2013 to March 2017 at an academic hospital in Vienna were included. Medical records were examined and follow-up interrogations of devices were conducted.Results: A total of 79 S-ICD patients (582% males) with a mean age of 44.5 +/- 17.2 years were followed for a mean duration of 12.8 +/- 13.7 months. A majority of patients (582%) had S-ICD for primary prevention of sudden cardiac death. The most common of the 16 underlying etiologies were ischemic cardiomyopathy, non-ischemic cardiomyopathy, and idiopathic ventricular fibrillation. The lead was implanted to the left sternal border in 96.2% of cases, between muscular layers in 72.2%. Mean implant time was 45 min, 3 patients were induced, and all patients except one were programmed to two zones. Six (7.6%) patients experienced at least one appropriate therapy for ventricular arrhythmias and the time to first event ranged from 1 to 52 months. Seven patients experienced inappropriate shocks due to T-wave oversensing, atrial tachycardia with rapid atrioventricular conduction, external electromagnetic interference, and/or baseline oversensing due to lead movement. Four patients underwent revision for lead repositioning (n = 1), loose device suture (n = 1), and infection (n = 2).Conclusions:While S-ICDs are a feasible and effective treatment, issues remain with inappropriate shock and infection.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Kardiologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cardiac and Cardiovascular Systems (hsv//eng)
Nyckelord
- arrhythmia
- complication
- subcutaneous implantable cardioverter-defibrillator
- sudden cardiac death
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas